Royalty Pharma plc (RPRX) NASDAQ

Currency In USD

Royalty Pharma plc

Address

110 East 59th Street

New York, NY 10022

United States of America (the)

Phone

212 883 0200

Website

https://www.royaltypharma.com

Sector

Healthcare

Industry

Medical - Pharmaceuticals

Employees

100

First IPO Date

June 16, 2020

Key Executives

Name	Title	Pay	Year Born
Pablo Legorreta	Founder, Chairman of the Board & Chief Executive Officer	44.02M	1963
Christopher Hite	Chairman of Partnering & Investments	1.32M	1967
Terrance Coyne	Executive Vice President & Chief Financial Officer	1.32M	N/A
Marshall Urist	Executive Vice President of Research & Investments	1.32M	1976
James Folmar Reddoch	Executive Vice President of Investments & Chief Scientific Officer	3.4M	1970
Arthur Richard McGivern	Executive Vice President of Investments & Chief Scientific Officer	3.4M	1975
Eric Cornelius Schneider	Senior Vice President & Chief Technology Officer	0	N/A
Sandy Balkin	Senior Vice President of Strategy & Analytics	0	N/A
George Grofik	Senior Vice President and Head of Investor Relations & Communications	0	N/A
Molly Sawaya	Executive Vice President & Head of Human Capital	0	N/A
Sara Klymkowsky	Senior Vice President of Research & Investments	0	N/A
Sam Landsberg	Finance and Treasurer	0	N/A
Kenneth Siming Sun	Senior VP & Head of Asia	0	N/A
Ashwin Pai	Executive Vice President of Investments & Partnering	0	N/A
Lucas Glass	Head of Artificial Intelligence	0	N/A
Scott Raichilson	Chief Accounting Officer	0	N/A

Description

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.